Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass

NT-proANP levels are reduced in hypertensive patients with metabolic syndrome and inversely correlate with left ventricular mass, suggesting a mechanism for left ventricular hypertrophy in this population.